XLV

softboiledjadepotato

QQQ and SPY just about at ATH. Perfect time to introduce new tariffs and a proposal to kill Health Care... rip XLV, UNH

GoProVI

Because stuff like this affects the market? Like everything 🥭 does… for example XLV is starting to drop pre market. Anything else?

TWSTrader

>**Viewing this from an institutional lens...** ignore the "Turnberry Deal" suspension. That is just political theater. The market largely expected that deal to die the moment the tariff tweet went out Saturday. The real "Black Swan" in this article—and the thing that should actually scare you—is the **"Anti-Coercion Instrument" (ACI).** Most retail traders have never heard of this because it has never been used. It was designed for China, but pointing it at the US is a massive escalation. Here is why the ACI is infinitely more dangerous than standard tariffs: **1. The "Nuclear Option": IP Stripping** Standard trade wars are about taxes (Tariffs). The ACI is about **Property Rights.** * **The Threat:** The article mentions *"lifting of intellectual property protections."* * **The Impact:** If the EU invokes this, they could theoretically tell European generic drug makers, *"Go ahead and copy Pfizer and Merck's drugs; we will ignore the patents."* Or tell European tech firms they can ignore US software licenses. * **The Trade:** This stops being a "Soybean/Farmer" problem and becomes a **Big Tech / Big Pharma** problem. **2. The "Asymmetric Warfare" of the ACI** The EU knows they can't win a tariff war (The US buys more from them than they buy from us). So, the ACI allows them to target **Services and Capital**, not just Goods. * *Investment Restrictions:* Blocking US Private Equity from buying EU assets. * *Procurement Bans:* Banning Microsoft or Amazon AWS from bidding on European government cloud contracts. **My Take:** Watch the language coming out of Thursday's meeting. * If they stick to **"Retaliatory Tariffs"** (Bourbon/Harleys): **Buy the Dip.** That is standard playbook stuff. The market knows how to digest it. * If they officially invoke the **ACI (The Bazooka)**: **Short the QQQ and XLV (Healthcare).** * US Tech and Pharma valuations are built on global IP protection. If that cracks, the premium evaporates. **The Timeline:** The EU moves at the speed of bureaucracy. They meet Thursday. Implementation takes weeks. You have time to hedge. Look at **Puts on US Multi-nationals** with >30% revenue from Europe, and rotate into **Domestic Small Caps (IWM)** or **US Defense (ITA)**, which are immune to European regulators.

TWSTrader

**Institutional background here (14 years).** The price action you are seeing today is what we call a **"Geopolitical Air Pocket."** You are right to be excited. The "Madman Theory" volatility (Trump threatening tariffs on NATO allies over Greenland/Trade) creates the best buying opportunities because the market is pricing in **Political Rhetoric**, not **Economic Reality.** Here is the institutional view on your specific points: **1. Why Financials Dropped (The Surprise)** You mentioned you didn't expect Financials to get hit. * **The Mechanism:** When "Tariff" headlines hit, money flees to safety (US Treasuries). This pushes bond prices *up* and yields *down*. * **The Impact:** Banks profit from higher yields (Net Interest Margin). When the 10-Year Treasury yield crashes because of a "Safety Trade," Bank algorithms sell off instantly. It wasn't a credit concern; it was a **Yield Curve** trade. **2. Your Healthcare Thesis** * **The Critique:** Healthcare is a **Defensive Sector** (Low Beta). It usually outperforms *while* the market is crashing (people still need medicine). * **The Rebound Reality:** However, if you believe this is a "Buying Opportunity" (meaning the market will recover), Healthcare is rarely the *first* to rip. * **The Trade:** When the "All Clear" signal comes (usually a Trump tweet walking back the threat), the sectors that were punished the hardest—**Tech and Semis**—will snap back the fastest (High Beta). * *If you want Safety:* Buy Healthcare (XLV). * *If you want Recovery Gains:* Buy the beaten-down Tech (QQQ/SOXX). **3. What happens next?** The "Trump Cycle" usually has a 72-hour half-life. * **Day 1 (Today):** Panic/Algo selling. * **Day 2 (Wednesday):** Stabilization. The administration likely leaks a "clarification" that the tariffs are a "negotiating tactic." * **Day 3 (Thursday):** The Relief Rally. **My take:** Don't chase Healthcare hoping for a rebound; buy it for protection. If you want to profit from the "Trump Dip," you have to buy the thing everyone is afraid of right now: **Big Tech.**

ThinkingOfTheOldDays

thanks. that's a bummer. healthcare factor was weak the past couple days too, avoidance of defensive sectors maybe. I think it's a good time for IYH and XLV.

Got_Engineers

That is why XLV option prices are all fucked this week. Calls had no value

ThinkingOfTheOldDays

healthcare sector has good momentum. $PINK, $XLV, $IYH, $IXJ

bb1180

I'm shifting some away from VOO and the tech sector and plan to invest more into VTV and some sector defensives (XLU and XLV) this year.

bb1180

I've started shifting away from VOO and tech and primarily into VTV, which I'll be adding along with XLU and XLV this year. I want to play this year more defensively.

xlmtothemoon

all in XLV? feel like healthcare is gonna outperform everything for once

Ok-Proposal6598

For having started in June, you're doing very well. Clearly, PLTR and NVDA have significantly boosted your portfolio; both have had an incredible year. The good: BRK.B as a value anchor is smart. Buffett isn't going to make you rich overnight, but he's not going to ruin you either. XLV gives you defensive exposure to healthcare. When tech falls, this will cushion the blow somewhat. The big tech companies (GOOGL, MSFT) are quality companies with real moats. Observations: PLTR at 23% is a lot of concentration in a stock that can move 10% in a day. It's risen like crazy, but it could also correct sharply. Consider not adding more for now and let your other positions grow. QQQ has much of what you already own (NVDA, GOOGL, MSFT). It's somewhat redundant, but not terrible. Your actual exposure to tech is probably 70%+ of your portfolio. It works when tech is rising, but it hurts when it corrects. What's missing: something international. Everything is US-based. Overall you're doing well, just be careful not to keep focusing on PLTR.

Sugamaballz69

“Value” “growth” “momentum” etc. keywords for ETFs are mostly marketing. You are not going to harvest more growth by choosing these funds, especially passively. The only one of these that has somewhat of a standing is value but you are not going to get that from a passive index, i can assure you. Its just marketing. I’d get rid of VOOG, VBR, XLV (don’t see the point in having 5% of this as VOO is already like 10% healthcare) Personally I would get rid of all crypto, has 0 inherent value. But i am also aware this is a touchy subject. 10% is still too much to put into a single purely speculative asset regardless of my personal beliefs on it. I usually allocate around 10% total towards speculative, and of that, no single speculative stock can take up more than 5%.  I’m surprised you dont hold any GOOGL or MSFT, and a heavy weighting into nuclear. Little odd but now im just nitpicking. You need to be past conviction to be fully settled. No worries though, these things take time until you reach that. At that point, you’ll most likely no longer be on reddit or at least no longer posting about your positions. Conviction in a portfolio usually doesn't ask what strangers think about it. I know thats harsh but its the reality

crazybutthole

if your real emergency fund is $50k - you could invest lets say $20-25k of it split sveral ways to diversify so if shut hits the fan and you have to sell not every thing goes down at once. say for example - if you dont need the dividends $15-20k in BOXX (box spread ETF that pays better than most treasuries and does not pay dividends) $5k SPYM $5k IEFA (or similar international fund) $3k SBUG (or similar gold fund) $3k UTES (utilities) $3k FV (sector fund that avoids tech) $3k XLV (healthcare) $3k RDVY (rising dividend fund) with the exception of SPYM - i think at least a few of these will maintain their value or go up when SPYM drops. just my opinion. not financial advice.

PltoMsnLXIXThe2ndMsn

You picked a bad time to do short term gains. Market is rotating out of speculative ai/tech and settling into reliable stocks for the eoy blues. My best, risk adverse advice is to buy a share of an ETF like XLV and hedge. For the record I sold off rocketlab and holding one of CRSPR since it's prob undervalued for the long term (1 year) Your best bet is to take one of those AI proofreading gigs on LinkedIn and buy a share with the money.

Crazy_Donkies

I have every idea.  Until fundamentals change in a specific ticker, consumer spending is curtailed, or unemployment actually increases I will disagree with you every day of the week.   They are in "bear market territory" (What ever that means, since it doesn’t imply corporate performance), because of previous rotation into AI and Tech.   It's presently all sentiment. I will point you to two tickers as source of the rotation and that this isn't fundamentals.  IWM.  XLV.

ThinkingOfTheOldDays

PHYS, EEM, IEFA, VEA, IWM, XLK, XLP, XLV some tech now maybe, in shares

TheInkDon1

Thank you, that means a lot to me! So, I haven't been doing this in earnest for long, really just 2 or 3 months. But it does make sense, intuitively, doesn't it? And I don't keep good records to where I can say my accounts went up this much over that long. But I can give you my last 3 trades to give you an idea. **XBI** has been my darling for 7 weeks now. On **10/22** I bought Dec'26 90-Calls for **25.85**. Today they're worth **36.95** at Midpoint here AH. That's 43% over 7 weeks (1 day short). Can we call that 6% per week and extrapolate? **XPH**: this one I broke my LEAPS rule because it doesn't have expirations out that far, but I liked its chart, and it was better than the runner-up I'd picked, which did have LEAPS options. On **11/18** I bought 17Apr26 39-Calls for 13.65. Today they're worth 17.90. 31% over 3 weeks exactly. 10% per week? **XLV**: this one I cut yesterday b/c it had been going down for 2 weeks. **11/18** bought the Jan'2**8** 120-Calls for **39.97**. (I was experimenting with max time on these.) I can't tell you what those would've sold for yesterday, because I had rolled them in to Jan'2fter a 1.4% XLV share drop from yesterday) those Calls are **36.50**. So a loss of 9% over 3 weeks, -3% per week. So like that: some winners, some losers, and so far I've kept the losers small by monitoring the trend of the underlying. Do we get to add 6 + 10 - 3% per week and 13, then divide by 3 to get 4% per week? I don't know, maybe there's a better way to do that.

TheInkDon1

Hi, it's right there near the top: >I find \[momentum\] on **ETFs** [like this](https://imgur.com/a/etf-screening-on-barchart-G2Q5UWp). >I screen by **3-month** performance, but look at *6-month* charts. I'm not looking for the most UP, but the *smooooothest.* So I do ETFs only, not stocks. And I screen for them on Barchart as the screen-capture video (the blue link) shows. You might need to have Barchart Plus for their "flipcharts" feature, but it's so worth it to me. Or just screen ETFs with options there or anywhere else, then chart them somewhere. I find [StockAnalysis.com](http://StockAnalysis.com) to be quick and easy to use. It makes quick, pretty charts like this one: [My current 3 ETFs](https://imgur.com/a/BDuibJB) Silver is choppier than I like, but the return made me buy it. XBI is my current benchmark. I've been in it and XPH for 6-7 weeks now. So looking at that 3-month view, do you see the relative smoothness of XBI & XPH? That's what I look for, over the choppiness of SLV. But today I had to cut XLV (have a look and you'll see why), and I couldn't find a replacement I liked as well as even XPH. So I scaled fully into SLV, which I'd been dipping my too into late last week. Does that help?

TheInkDon1

You're welcome! As a data point, I bought **XBI** (the blue line) on 10/22, 6.5 weeks ago. The LEAPS Call I bought was the Dec'26 91-strike for **25.19**. That guy is worth **38.17** today. A gain of (38.17 / 25.19) = **51%** I'd apy that from 6.5 weeks, but it gets stupid. I'm also in **XLV** (which I don't recommend right now), and **XPH**, which hasn't done quite as well as **XBI**, but is solid. And the beauty of buying LEAPS Calls is that you can dial in the amount of leverage you want. I want really-good-but-sorta-safe leverage, so I buy at just over 1y and at 90-delta. Let me show you how the leverage calc works: Tomorrow I might buy the 376DTE XBI Call at 90-delta, the 94-strike, for **35.13** at Midpoint tonight, Sunday. XBI shares were last at **123.41**. How many of those Calls could you buy for the same money as 100 shares? 123.41 / 35.13 = **3.5** I kind of call that the *gross* leverage. Because it does answer that question, but it doesn't yet tell us how much faster the Call's price rises as the share price rises. For that we need to factor in the Delta of 0.90, which just means that the Call appreciates 90% as much as the shares: 90 cents on a $1 rise. So we multiply that 3.5 by 0.9 and get **3.1x** *net* leverage. But you might not want that much leverage. ***Because leverage cuts both ways.*** So you might go as far out as **XBI** has options, 775DTE/2.1y, and buy not at 90-delta, but at the first *100-delta* Call you find, the 80-strike. *Do you think it will cost more? And why?* Try to answer before reading ahead. Because it's farther out in time, it has more "what-if" potential, so yes, it will cost more. And because it's deeper ITM, you're paying for more 'equity' in the ETF. Okay, so he sells for **50.00**. Rembember that the first one sold for just 35.13, so you can see that the denominator of our calc is larger, leading to a smaller output. But here we get to multiply by 1.00, not 0.9, so we don't get that Delta reduction. So: 1.00 x (123.41 / 50.00) = 2.47x leverage. 3.1 before, 2.5 now. If you want even less, then slide up in the Call chain to lower strikes. They go down to 50, which gives a leverage of 1.6. So you see, you can dial in anywhere from 1.6x to 3.1x leverage on XBI, to suit your needs. And if I didn't say it before: deep-ITM LEAPS Calls act as share substitutes, giving us that leverage. So don't think of them as "option things," but just shares on steroids.

A1ien30y

This and only this. QQQ, VOO, SPY, XLV(for some of that medical diversification), ARKK and pick some dividends. Let know if I miss any other good ones.

Terakahn

FIX, GOOGL, ALAB. If I thought it was a bullish year. I'm not convinced. So. AEM, XLU, XLV.

ServerTechie

JEPI might be a good investment choice for him. High yield and low volatility. It won’t help with long term growth, but aggressive investing in his 60s could make you both uncomfortable. There are some low volatility equity ETFs out there that might interest you like SPLV, USMV, VFMV, but all of them still had significant drawdowns in 2020 and 2022 like everything else. Another option might be defensive ETFs, but don’t expect S&P level performance: XLU, VDC, XLV, SPHD. I sympathize, my father never invested in the market either. He had a good run living off his own parents until they died and he inherited a fortune in assets, but given his nature he blew thru millions in only a few short years. Now any bills not covered by social security fall to my sister or me. 😡

Wowmuchrya

When the recucklicans deny the ACA credit extension, like they always planned to do, XLV will crater. Already started selling off today from all the insiders lmao. Imagine being stupid enough to end the shutdown for a promised "vote" on extensions. 🤦‍♂️

SouthernBySituation

Sold CURE (3X leveraged XLV) when it broke the 50 day hard on Sept 25th and closed at the low of the day. Next 4 days healthcare did a U-turn and the sector that was so hated at the time has led the market since. CURE did 21%+ in 4 days. Missed a 50%+ move overall. Buying and sitting on oversold sectors is the way.

Morely7385

If it were me , I’d stop anchoring to the old high and plan a staged exit: harvest the loss, rotate most into XLV or VHT, and keep a small tracker or use covered calls for any rebound. What I’d do: sell enough now to lock the tax loss, buy XLV/VHT the same day so you keep healthcare exposure, then wait 31 days before deciding if PFE deserves a spot again. Earnings is a coin flip, so let the ETF carry the sector bet. If you want upside while exiting, write 30–60 day covered calls on the leftover shares and let assignment take you out on strength. To justify holding at all, I’d want clear signs on integration/execution, debt paydown pace, R&D updates, and guidance revisions, not hopes for another vaccine spike. For prep, I use Koyfin for ETF look‑through and Portfolio Visualizer for simple backtests, and Ask Edgar to skim filings and transcripts fast before earnings. Main point: set a rules-based exit, TLH into XLV/VHT now, and only keep a small, managed PFE slice.

Crazy_Donkies

Many Healthcare stocks did.  Plus we keep hearing this administration attacking healthcare costs (rightfully so).  So I pulled out of XLV and XLV calls this week and am focusing on the hopeful shift to IWM.

SpongEWorTHiebOb

been a dividend trap and “turnaround “ story for 9 of the past 10 years. Tax loss harvesting may keep it depressed through year end. It may pop a bit in the new year as people rotate into new plays. I’d look to sell before their next earnings date and reinvest proceeds in VHT or XLV. It’s very hard predicting a winner in this space. The science is hard and so many of them overpay for acquisitions that it’s best to invest in one of the ETFs. The ETFS have caught on fire past few months after 2 years of low returns. The sector will probably outperform next 2 years.

TheInkDon1

You're welcome, and I'm glad you're trying it! I've been loving XBI since 10/22, and added XLV and XPH more recently because they screened in for 2 ETFs I was cutting. I AM very concentrated in that area though, aren't I? But I don't look for ETFs that I *think* might do well; I simply find the ones that *are* doing well. Have you seen [how I screen on Barchart](https://imgur.com/a/etf-screening-on-barchart-G2Q5UWp)? You might need to pay for Barchart Plus to be able to do some of the steps, but the Flipcharts feature is more than worth it to me. But however you screen, **look at charts**, and look for *smoooooth*. I'll pick an ETF that's doing 'just' 2% a month over one that's doing 10% if it's a smoother ride. Because I know I can leverage that to something like 6%/month, and that's enough for anybody. And I don't have to worry too much about buying in on the wrong day and it tanks a day or three after. Because that hurts when you're buying LEAPS Calls. I just screened again, 3-month performance, Has Options, Volume >700k, then looking at 6-month charts: **XBI** was #1. That thing is up 53% over 6 months. Buy the 90-delta Call at 388DTE and you're getting 3.1x leverage after adjusting for Delta. That's huge. Silver and its miners, plus the gold miners GDX & GDXJ were next, and they're making me think it might be time for me to get back into precious metals. **IBB** was next, but of course it's another biotech. Still, 40% over 6 months, and look how smooth. Then **GLD** and other gold ETFs. Gold had a great runup since late 2023, and I caught some of it this year, but gave some of it back too after the peak on 10/20. I'll probably get back in if/when gold clears 4,200. Take care, Mike

frank_uptrendinsight

It may not appear this is an everything bubble. Without a doubt Tech (XLK) has been challenged in the last month as it's performance is lagging every other sector during that time period but Healthcare (XLV) has been strongest sector in the last month with about a 6.5% return. Now, that is a defensive sector so perhaps what we are seeing is investors run to safety in this market. With major indexes at 4 week lows we will have to see whether this is a rotation out of high P/E AI names into safety/value or if we are entering a correction or bear market.

Terakahn

GLD, XLV, XBI. AI and commodities run for way longer than people think. But I wouldn't do any of these I'd just pick stocks

MrT_IDontFeelSoGood

Somehow XLV is holding in there. I’m wondering if we’ll get a whoosh down across all markets this week. Tension is definitely building.

toasty_mintz

The rotation is clearly into XLV. And the odds of a cut in December are now sub .500… until economic data is released again, and internalized by the market it’s going to be a tough market to trade.. buying off the 50 Day MA is one simple strategy

Medical-Chapter-1410

hold my shit! everything is getting obliterated. LOL My only saviour is GOLD and XLV and even that is getting spanked now. LOL

explorer77800

I loaded up on XLV the last 6 months while was going down, and everything else was and is way overvalued. Feels great right now.

explorer77800

Love me some sector ETF investing. Loaded up on XLV the last 6 months and nothing but straight up lately. Love it.

Crazy_Donkies

XLV (healthcare) is up over 1%.

TracyM45

Schumer loses 1.5 trillion profit for Insurers.Short XLV

ThinkingOfTheOldDays

XLV same chart pattern every day. moons until 10, sells off hard

ThinkingOfTheOldDays

XLV january OPEX 145c

ThinkingOfTheOldDays

I bought the top on XLV. until tomorrow

ThinkingOfTheOldDays

I bought the top on XLV. until tomorrow.

ThinkingOfTheOldDays

XLV is breaking out imo. good anchor for your long term, not gambling portfolios.

explorer77800

Not a stock but the healthcare as a sector has been cheap for the last year. Seems like the only sector out of the economy. Look at XLV.

InfinitePhotograph61

Combine XLV with SPDW and SPEM if you really want to focus on healthcare, believe in it for the long term. Spreading risks, with high risk/high reward with SPDR(emerging) with the balance of XLV(US Large), SPEM(Developed countries).

FactorFair3363

XLV and UNH (because of insiders) are great options

InquisitorCOC

$XLV in addition to other comments here I personally loaded up on $UNH after Buffett, Tepper, and its insiders

Alive-Vacation-8033

Buy XLV. It’s like tech’s chill cousin that still brings dividends to family dinner.

WeenieWang_

Probably XLV. It does exactly what you just said.

80delta

If XLV and SPY stay bullish, Healthcare stocks. MRK, MRNA, RXRX, CNC, SRPT all on the radar. I'll figure out which one/s based on the morning price action.

TiredElephant_c

Healthcare underperforming the rest of the market to an extent that hasn’t been seen since the early 2000’s, this is a graph of XLV / SPY, the Healthcare Select sector index over the S and P 500: https://preview.redd.it/w84dk8uircsf1.jpeg?width=1259&format=pjpg&auto=webp&s=f0ed5ede4842defe4557636d4b54b185b26c6f54 Pretty remarkable, the stink on healthcare lately

TiredElephant_c

https://preview.redd.it/wl7rhqt0lcsf1.jpeg?width=1806&format=pjpg&auto=webp&s=21cb004997a908eb26c1455d13ac0738376f5bc7 XLV has underperformed SPY and the rest of the market more severely than it has in 2 decades. I’ll show some photos to illustrate below. Aside from healthcare being a defensive and dead sector in recent years (and the large patent cliff threatening a lot of the established and profitable healthcare companies), I think a lot of it is just the nature of pharma / biotech / healthcare investing. It can be high risk high reward, highly catalyst based, often burning cash with negative earnings for extended periods of time with many capital raises and dilutions, long trials that are sometimes make or break binary events. In the current hot market where there are a lot of opportunities, not many people have the patience to wait through several years of trials and a lot of them, especially the preclinical ones without diversified pipeline assets or some way to make money and positive cashflow, wittle down to zero until their next catalyst or data release comes along and that’s where most of the important gains or losses come from. That’s just how pharma is. Huge gaps and catalyst / data readout driven. As for why a lot of analysts rate these companies a buy while they slowly wittle down to 0, I think part of it is that there’s probably in reality little difference between what analysts rate a buy in biotech versus what is rated a buy elsewhere, it maybe stands out more to see a buy slapped on a bunch of companies that are slowly bleeding their share price down to nothing while waiting for the next catalyst or trial result. If not that, I would guess that maybe these companies are a buy in the sense that if they are successful in their mission or whatever product they’re trying to create it will be a profitable venture but like I explained, in this sector that is often a long and arduous road with years of expensive trials and long lead times that only payoff once people see the data and the results and the drug starts getting manufactured and sold, which is a whole challenge in itself for a lot of these companies who often have no experience with distribution and commercialization and production ramp up.

AlphaHarmony

I get tech taking a breather, but what is going on with healthcare? XLV drilling

PapaCharlie9

I like the SPDR series of sector funds, since they tend to have reasonable options liquidity. Healthcare = XLV Energy = XLE Doesn't look like they have an X--- fund for AI.

Cautious_You7796

I’ve been steadily taking profits out of big winners like Shopify and the quantum computing stocks and moving it into lagging ETFs like XLP and XLV.

adminsarecommienazis

Overpriced: MCD - Trades at tech multiples. Sales are weakening. Can't keep increasing margins without people running away. Chipotle already got hit hard here. People say companies like McDonalds do well in a recession, but I just don't think this is true anymore at current prices. If we do get a recession, I don't think its the safehaven people assume it is. Underpriced: PFE, MRNA - But more the entire XLV complex, particularly big pharma. Healthcare got destroyed this year, but it seems more based on fear than substance at first glance. There will always be need for drugs. Even if there's no taste for mandatory jabs or lockdowns, there's nothing stopping China from releasing a new virus if they need leverage down the road. I don't know if any pharma companies are exploring AI yet, but it could also be a huge boon to drug discovery or diagnostics. You could also make a more direct play on companies like NVO that make Ozempic and its cousins. There's a lot of really impressive designer drugs around the corner, and I see them really taking off over the next decade or so.

crazybutthole

Why do you feel like choosing three stocks and holding them for a long time is the best decision? If I had to choose three investments and hold for 15 years - I would choose: QQQ + VTI + VOO But I don't have to hold just three investments. So I have 25% in each of those three. And the other 25% I have spread around in other ETFs and some individual stocks. Like MAIN, COST, HTGC, AMZN, GOOGL, XLV and a few others.

rascallyrascal1511

Yep. Just opened my position in XLV.

old_Spivey

Halt die Klappe! Felix is a brilliant guy with a fantastic personality. His ideas are very sound and can lead to substantial gains. As another poster stated above, he does find good investments before some of them really take off. The wins far exceed the losses and if you set stop losses, you will continue to gain in a bull market. If it is a volatile stock you can't set the loss at the buy point or you'll likely get kicked out of your trade. You have to take some risk, usually 5-7%. If you lose that 5-7%, you chalk it up to the cost of business and let it be offset by your other trades of 10-20%. Diversification is also key, although paying attention to the moving sectors will help a lot.( I personally watch the XL funds: XLE, XLF, XLV, XLK etc) I have not paid for his GOAT Academy because I don't have the funds for it now. But I do enjoy his erudite humor, his pets and the approach he takes. Like others who have stated before me: if you don't like it, don't watch. What miserable wretch expends their energy trying to find fault with someone they supposedly don't care about?

Asleep-Strike4978

So far up 12k. Sold CSP on UNH, CNC, and TTD. XLV and IWM up nicely.

explorer77800

Hence why I’ve been loading up on XLP. And a little XLV. They’re very reasonably priced right now and their time will come, and in the meantime I see them flat at worst case, they will never significantly drop in value

andytobbles

Current positions - leaps on XBI, AMD, GLD, WMT, XLV. Full defense with a splash of AMD

Fhyzikz

I got a neat -$300 today thanks to MSFT, COST, and XLV wiping out most of my gains from last week. Super

Fhyzikz

XLV is going to 0. Every time I sell things for a loss though, that thing shreks to the moon the next day so idk

lipmanz

Healthcare is one of the only industries doing well but you would never know that by the XLV

Drascilla

Yeah and if you don't know which healthcare company to choose, you can still invest in $XLV which is a healthcare ETF. Still down 9% since last year, but looks like recovery is underway.

alone-in-the-chat

So having XLV SCH and BND was a good idea

NoviceAxeMan

yeah mine is holding XLV thought that would be fitting since it’s a health focused investment account

Flimsy_Complaint490

I full ported XLV leaps instead on Thursday. Only risk i see to healthcare is the tariff, but if its a nothingburger like the semi tariff, then all healthcare has bottomed out and UNH 450 EOY and XLV 150 EOY

RobotPimpLibertyBell

i'm playing it through XLV

RobotPimpLibertyBell

Actual moves. Closing my AAPL $205 calls from a month ago. Riding XLV December calls for a catch up trade in health care.

Bittygirl707

CLOV Clover Health 01:53 PM EDT, 08/12/2025 (MT Newswires) -- Health care stocks rose Tuesday afternoon, with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) adding 0.4%.

AcademicStandard3701

XLV is kinda a steal right now 😋

Hot-Pop-3250

XLV looks like it could go below 120 before making a comeback. Might wait a few days to see though

Sidney1973

XLV is my yolo move.

Sidney1973

XLV puts. 1/27 EXP

zxc123zxc123

It's a good thing I only sold cash covered puts on UNH during spring during the first knife fall. Stopped selling UNH puts and was waiting on earnings. Sold XLV puts instead and it's working out well. Also UPS earnings came out first and sold some puts. Clearly I sold too early thinking it would break too much lower than pandemic era prices, but here we are. At least I'm still OTM. If I didn't go into UPS or if UPS didn't keep shitting the bed then I'd consider some UNH puts but atm I'm full on UPS puts.

explorer77800

I have a good amount in XLV. I’m long just given the basic need and commodity of healthcare long term. I’d be hesitant to pick individual stocks in the sector but I feel good buying the sector. Every other sector has been soaring. When a macro rebalance eventually happens I think healthcare will benefit. Might be years away but in didn’t buy them high and just randomly trickling in as XLV stays low.

jraiv420

Whole healthcare sector getting it's shit rocked, XLV smoked

piejlucas

Investors in XLV today better have good health insurance.

andytobbles

If you ain’t buying XLV calls before UNH earnings wtf you doing

kindofblue603

Take a lesson from the stock market in the year 2000 (peak of the internet stock bubble) and what did well from 2000-2003 during the tech crash. Rotation into more value-based stocks in Finance, Energy, Utilities, and Health Care. Check out the holding lists from value-tilted ETFs like MOAT and SPGP to get some ideas. During a rotation to value, you can never go wrong with BRKB-its already on the upswing. If you want less risk than individual stocks then try the sector ETFs of XLF, XLE, XLU, and XLV. Looking at the ratio percent change of XLK(technology sector) vs XLV(health care sector) over a period of time can give you an idea of how much rotation is going on into value. This past week (7/26) the ratio is over 10.

Wowmuchrya

Lol, gg. These autists sold out of every XLV/healthcare stock and are funneling into chips. Centene earnings musta got leaked or some shit.

mrmrmrj

If you want to short a stock, I recommend buying an ETF with the proceeds of the short. This is called a paired trade. Short TSLA, Buy QQQ. Or you can even make the long trade a further bet against the short. Long XLV (healthcare ETF which has been battered), Short PLTR.

Kris_Mettew

From a portfolio construction standpoint, you’re effectively betting that Nvidia will continue to outperform all other opportunities. Historically, concentrated positions can generate wealth, but diversification is how you preserve it. Even legendary investors like Peter Lynch and Warren Buffett warn about overconcentration, unless you have asymmetric insight or control. A practical move would be to rebalance incrementally, start trimming maybe 20–30% of your NVDA and reallocate into low-cost, high-growth ETFs like VGT or QQQ for sector exposure, or SCHD/VTI if you want broader diversification with dividend exposure or total market. You’ll maintain tech upside while reducing single-stock risk. Consider adding non-correlated assets too, like energy (XLE), healthcare (XLV), or even a slice into international (VXUS). If you’re still long-term bullish, you can re-enter later at better valuation points or just hold a reduced core position. Also factor in tax implications, if this is in a taxable account, you’ll be triggering capital gains, so tax-loss harvesting or spreading sales over multiple years might help. If it’s in a tax-sheltered account, it’s more flexible. The key is not to abandon NVDA, but to recognize that protecting your gains is a smarter move than riding euphoria.

Wowmuchrya

The market doesn’t care about anything besides tech stocks. UNH long is a logical play. The majority of the damage should have been done when UNH pulled guidance last earnings, but no clown retard institutions are still surprised when Centene and others follow suite and lower guidance as well. The problem with health stocks rn is that when UNH pulled guidance and dropped 30% 4 months ago all of XLV should have dropped 30% with it, but no now it’s just a self perpetuating loop where company after company lowers guidance and the ones that already did lower guidance get hit algorithmically.

Cautious_You7796

Individual stocks not really but I have been taking profits and using said profits to buy XLV. It's really beaten down compared to other sectors so eventually it should come back around.

Aumin85

Do what you feel is right, but you don't really want to invest in healthcare for the gains necessarily. It's more to protect your portfolio should downturns arise. XLV has gained in 5 years, just not as much as things like VOO or QQQ.

Ok_Atmosphere3601

I did look at XLV. It's traded sideways for the last 4 years. The recent correction has it down just 15% so it seems it's not really in value terittory.

Aumin85

XLV is a high quality ETF for the healthcare sector. It isn't performing great atm due to the reasons you mentioned however.

Any-Inspection-3325

congrats to all who have heed our call to sell semis and rotate into defensives and small caps, enjoy ur big gains later! we are intending to bring QQQ down to .7-.9% along with SMH -2% while rotating to XLV XHB XBI and consumer defensives

I_am_Nerman

XLV getting destroyed today

Any-Inspection-3325

as forewarned early we are rotating to consumer defensives and laggards KHC CPB XHB KO MO TGT PG BRKB XLV hope everyone is happy with their profits from the puts! u can load on more 14/30DTE puts as we will continue to dump till mid oct

IntelligentDamage824

i have found the X ETFs and I’m like a child in a candy store. easy but steady gains and low barrier to entry. XLE - energy XLF - finance XLV - healthcare list goes on & on

cscrignaro

It hasn't touched that MA on the monthly and ELV earnings I doubt will affect it. UNH is #4 in XLV whereas ELV is 21st. The two show little correlation to eachother. If anything ELV is weaker and their earnings would provide sentiment at best. It is not something I'm watching for no.

cscrignaro

Can't a man have fun? I generally like XLV long and UNH is it's 4th holding. I think money rotates out of IWM/QQQ and into XLF/XLV. With BTC at ATHs risk is on and profits rotate. SPY is likely to keep trekking higher while QQQ see's choppy consolidation and the sectors that haven't run like XLV do so. XLF is getting a last leg up before consolidation it seems and if profits are going to rotate it's likely into healthcare IMO. Could be wrong, one day at a time. Right now, my risk-reward is favourable.

Affectionate-Idea690

SPy id the messenger of them all....XLY XLV are some areas gaining highly today...

housetheimpaler

My portfolio consists of SPY. BROs. VICI. XLV. and TTWO I’m a long term investor and I am just looking for advice i guess

AffectionateAd3773

Hey man, you're spot on – today's numbers were definitely a mixed bag and didn't really light a fire under the market. Like you said, maybe a *slight* hint of weakness pushing the dollar down, but nothing crazy. It's interesting though, if you look a bit deeper, that drop in 'core capital goods orders' (basically, what businesses are ordering, minus defense and planes) falling 1.3% *is* a bit of a heads-up. It suggests companies might be getting a bit cautious with their spending. That often gives a clue about how industrial stocks (like XLI) and smaller companies (like IWM) might do, and both have been a bit sluggish lately, so it kind of fits. This ties into the bigger 'vibe' of the economy right now – feels like we're in a phase of slower growth but also low inflation. If you look back at times like these, usually 'safer' bets like healthcare (XLV), low-volatility stocks (SPLV, USMV), and solid bonds (AGG) tend to hold up better. Just thinking out loud, but it's a pattern worth watching. If you're into this 'big picture' macro stuff and how it can connect to your own investing, we actually break down these economic 'regimes' and share model portfolios based on them over on our site, [**macrolookup.com**](http://macrolookup.com), which you can check out. We try to make institutional-level insights accessible for regular investors. Might be helpful if you're looking for ways to navigate these kinds of markets! Hope this helps add another angle to your thinking.

HappyHourMoon

I would wait until they find a new CEO or better yet buy an etf for the healthcare sector like XLV

courage_and_honour1

I don’t touch individual health names. I just buy XLV whenever it dips below 130